Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Jan Oldenburg, Sophie D. Fosså et al.|European Urology|2023Cited by 13
Abstract 481: Utility of hCG as a biomarker of treatment response in advanced urothelial cancer: A population based series at Akershus University Hospital, NorwayKatarina Puco, Jan Oldenburg, Johan Bjerner et al.|Cancer Research|2021Cited by 1